Q&A with Oncimmune CEO, Martin Gouldstone

Episode 1718,   Nov 24, 2023, 01:43 PM

(Watch the video interview HERE)

In this interview, CEO Martin Gouldstone of Oncimmune (ONC) - a global leader in immune biomarkers and immunodiagnostics – takes Vox Markets through:

00:00 His first impressions of the business & how ONC's services are used in the field.
07:00 Revised commercial strategy
17:45 Current health of the sector
21:20 Size of the addressable market
28:55 Roadmap & timelines ahead